Literature DB >> 4715566

A fluorometric assay for daunomycin and adriamycin in animal tissues.

H S Schwartz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4715566     DOI: 10.1016/0006-2944(73)90060-4

Source DB:  PubMed          Journal:  Biochem Med        ISSN: 0006-2944


× No keyword cloud information.
  28 in total

1.  Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to acute gastrointestinal toxicity of doxorubicin.

Authors:  Jing Li; Shufeng Zhou; Hung Huynh; Wei Duan; Eli Chan
Journal:  Pharm Res       Date:  2005-08-13       Impact factor: 4.200

2.  Distribution and antitumoral activity of adriamycin combined with warfarin in mice.

Authors:  P Ghersa; M G Donelli
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Quantitation of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration.

Authors:  A Andersen; D J Warren; L Slørdal
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  Development and identification of a multicompartment model for the distribution of adriamycin in the rat.

Authors:  P Sonneveld; J A Mulder
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

5.  Iron oxide nanoparticle-based magnetic resonance method to monitor release kinetics from polymeric particles with high resolution.

Authors:  Minnie Chan; Eric Schopf; Jagadis Sankaranarayanan; Adah Almutairi
Journal:  Anal Chem       Date:  2012-09-04       Impact factor: 6.986

6.  Radioactive species in rat urines and tissues after [14C] AD 32 administration.

Authors:  G Zini; G P Vicario; M Lazzati; F Arcamone
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

7.  Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.

Authors:  F Formelli; A M Casazza; A Di Marco; A Mariani; C Pollini
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Distribution of doxorubicin to normal breast and tumour tissue in patients undergoing mastectomy.

Authors:  S Stallard; J G Morrison; W D George; S B Kaye
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

9.  Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors.

Authors:  F Formelli; C Pollini; A M Casazza; A di Marco; A Mariani
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

10.  Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin.

Authors:  J H Doroshow; G Y Locker; C E Myers
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.